CORD-19:2e2bc679c8393230bac2af64115bab7ed1ba62c0 / 445575-445809 JSONTXT

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T365","span":{"begin":0,"end":234},"obj":"Sentence"}],"text":"At T0 (basal), T1 (after fi rst cycle), T2 (after second cycle), T3 (after third cycle) and T4 (after fourth cycle) we evaluated haemodynamic parameters, norepinephrine dosage, PaO 2 /FiO 2 ratio, plasma IL-6, and procalcitonin (PCT)."}

{"project":"CORD-19-Sentences","denotations":[{"id":"T27127","span":{"begin":0,"end":234},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"At T0 (basal), T1 (after fi rst cycle), T2 (after second cycle), T3 (after third cycle) and T4 (after fourth cycle) we evaluated haemodynamic parameters, norepinephrine dosage, PaO 2 /FiO 2 ratio, plasma IL-6, and procalcitonin (PCT)."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T1360","span":{"begin":229,"end":232},"obj":"Disease"},{"id":"T23312","span":{"begin":229,"end":232},"obj":"Disease"}],"attributes":[{"id":"A1360","pred":"mondo_id","subj":"T1360","obj":"http://purl.obolibrary.org/obo/MONDO_0008296"},{"id":"A1361","pred":"mondo_id","subj":"T1360","obj":"http://purl.obolibrary.org/obo/MONDO_0015104"},{"id":"A71881","pred":"mondo_id","subj":"T23312","obj":"http://purl.obolibrary.org/obo/MONDO_0008296"},{"id":"A67740","pred":"mondo_id","subj":"T23312","obj":"http://purl.obolibrary.org/obo/MONDO_0015104"}],"text":"At T0 (basal), T1 (after fi rst cycle), T2 (after second cycle), T3 (after third cycle) and T4 (after fourth cycle) we evaluated haemodynamic parameters, norepinephrine dosage, PaO 2 /FiO 2 ratio, plasma IL-6, and procalcitonin (PCT)."}